Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 3
1963 1
1964 1
1966 2
1967 4
1968 3
1969 1
1970 4
1972 4
1973 1
1974 5
1975 2
1976 2
1977 2
1978 3
1979 1
1980 4
1981 2
1982 5
1983 2
1984 1
1985 1
1986 3
1987 3
1988 6
1989 2
1990 3
1991 1
1992 6
1993 5
1994 2
1995 4
1996 6
1997 5
1998 4
2000 1
2001 2
2002 2
2003 5
2004 2
2006 2
2007 3
2008 2
2009 2
2010 5
2011 1
2012 4
2013 5
2014 10
2015 10
2016 16
2017 11
2018 10
2019 14
2020 6
2021 23
2022 7
2023 13
2024 11
2025 7
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS Collaborators. Furuta S, et al. JAMA. 2021 Jun 1;325(21):2178-2187. doi: 10.1001/jama.2021.6615. JAMA. 2021. PMID: 34061144 Free PMC article. Clinical Trial.
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.
Jo T, Yoshihara S, Okuyama Y, Fujii K, Henzan T, Kahata K, Yamazaki R, Takeda W, Umezawa Y, Fukushima K, Ashida T, Yamada-Fujiwara M, Hanajiri R, Yonetani N, Tada Y, Shimura Y, Nishikii H, Shiba N, Mimura N, Ando J, Sato T, Nakashima Y, Ikemoto J, Iwaki K, Fujiwara SI, Ri M, Nagamura-Inoue T, Tanosaki R, Arai Y. Jo T, et al. Among authors: mimura n. Br J Haematol. 2023 Jul;202(2):256-266. doi: 10.1111/bjh.18831. Epub 2023 Apr 25. Br J Haematol. 2023. PMID: 37096915 Free article.
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression.
Matsui S, Ri C, Bolanos LC, Choi K, Shibamiya A, Ishii A, Takaishi K, Oshima-Hasegawa N, Tsukamoto S, Takeda Y, Mimura N, Yoshimi A, Yokote K, Starczynowski DT, Sakaida E, Muto T. Matsui S, et al. Among authors: mimura n. Leukemia. 2024 May;38(5):1032-1045. doi: 10.1038/s41375-024-02245-3. Epub 2024 Apr 12. Leukemia. 2024. PMID: 38609495 Free PMC article.
Novel therapeutic strategies for multiple myeloma.
Mimura N, Hideshima T, Anderson KC. Mimura N, et al. Exp Hematol. 2015 Aug;43(8):732-41. doi: 10.1016/j.exphem.2015.04.010. Epub 2015 Jun 26. Exp Hematol. 2015. PMID: 26118499 Free PMC article. Review.
[Hemodialysis].
Mimura N, Takuma T. Mimura N, et al. Nihon Jinzo Gakkai Shi. 1972 Jan;14(1):27-30. Nihon Jinzo Gakkai Shi. 1972. PMID: 4674314 Japanese. No abstract available.
Clinical Practice Guidelines for the Management of Congenital Cytomegalovirus Infection in Japan 2023: Executive Summary.
Ito Y, Morioka I, Takahashi N, Fujioka K, Miura K, Moriuchi H, Morimoto N, Yoshikawa T, Ashina M, Abe S, Imafuku H, Uchida A, Okahashi A, Kakiuchi S, Kakimoto Y, Kawata S, Kawamura Y, Kido T, Kidokoro H, Kozawa K, Samejima T, Suzuki T, Tanimura K, Tomonaga C, Torii Y, Nakanishi M, Nagano N, Nagamatsu T, Narita H, Nishimura K, Nonobe N, Hasegawa Y, Hara K, Hijikata M, Fukuda T, Funato Y, Mimura N, Yamamoto N, Yoshitomi A, Kakei Y, Kodama T, Oka A. Ito Y, et al. Among authors: mimura n. Pediatr Infect Dis J. 2024 Nov 1;43(11):e390-e396. doi: 10.1097/INF.0000000000004489. Epub 2024 Jul 29. Pediatr Infect Dis J. 2024. PMID: 39079035
Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myeloma.
Jo T, Yoshihara K, Ri M, Tsukada N, Mimura N, Fujii K, Fukushima K, Fujiwara SI, Shimura Y, Haraguchi K, Kato K, Satake A, Yoshida A, Suzuki R, Ikemoto J, Iwaki K, Takeda W, Yonetani N, Tanosaki R, Yamada-Fujiwara M, Kahata K, Nagamura-Inoue T, Yoshihara S, Arai Y. Jo T, et al. Among authors: mimura n. Blood Neoplasia. 2024 Oct 24;2(1):100051. doi: 10.1016/j.bneo.2024.100051. eCollection 2025 Feb. Blood Neoplasia. 2024. PMID: 40546722 Free PMC article.
263 results